2071 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Zelenetz
    Zelenetz
  4. Yahalom
    Yahalom
  5. Cheung
    Cheung
  6. O'Reilly
    O'Reilly
  7. Kushner
    Kushner
  8. Perales
    Perales
  9. La Quaglia
    La Quaglia
  10. Giralt
    Giralt

Groups

  1. Department of Medicine (1047)
  2. Center for Hematologic Malignancies (589)
  3. Hematologic Malignancies, Division of (537)
  4. Survivorship Research (532)
  5. Solid Tumor Oncology Division (487)
  6. Pediatrics, Department of (383)
  7. Surgery (287)
  8. GSK Faculty (276)
  9. Breast Medicine Service (255)
  10. Tow Center for Developmental Oncology (TCDO) (240)
  1. "cyclophosphamide"
Formats
  1. Journal Article (1932)
  2. Review (52)
  3. Conference Paper (46)
  4. Editorial (11)
  5. Research Letter (11)
  6. Meeting Abstract (8)
  7. Correspondence (6)
  8. Guidelines (4)
  9. Book Section (1)
Groups
  1. Department of Medicine (1047)
  2. Center for Hematologic Malignancies (589)
  3. Hematologic Malignancies, Division of (537)
  4. Survivorship Research (532)
  5. Solid Tumor Oncology Division (487)
  6. Pediatrics, Department of (383)

More Groups

People
  1. Clifford Hudis (130)
  2. Larry Norton (104)
  3. Andrew Zelenetz (75)
  4. Joachim Yahalom (72)
  5. Nai-Kong Cheung (71)
  6. Richard O'Reilly (67)

More People

Years
  1. 2025 (45)
  2. 2024 (86)
  3. 2023 (56)
  4. 2022 (44)
  5. 2021 (23)
  6. 2020 (46)

More Years

Publications
  1. Journal of Clinical Oncology (155)
  2. Cancer (109)
  3. Blood (81)
  4. Leukemia and Lymphoma (50)
  5. Biology of Blood and Marrow Transplantation (49)
  6. Bone Marrow Transplantation (48)

More Publications

Publishers
  1. Elsevier Inc. (345)
  2. American Society of Clinical Oncology (163)
  3. Wiley Blackwell (150)
  4. Springer (147)
  5. American Society of Hematology (113)
  6. Lippincott Williams & Wilkins (112)

More Publishers

Results (2071)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Transplant for non-malignant disorders: An International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering
    Guidelines

    Klein, O. R.; Bonfim, C.; Abraham, A.; Ruggeri, A.; Purtill, D.; Cohen, S.; Wynn, R.; Russell, A.; Sharma, A.; Ciccocioppo, R.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice
    Journal Article

    Sanchorawala, V.; Wechalekar, A. D.; Kim, K.; Schönland, S. O.; Landau, H. J.; Kwok, F.; Suzuki, K.; Dispenzieri, A.; Merlini, G.; Comenzo, R. L.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Tocilizumab in the treatment of eosinophilic fasciitis: A case study and review of literature
    Review

    El Iskandarani, S.; Khasho, M.; Merashli, M.
    Mediterranean Journal of Rheumatology (2023)

    Fulltext@MSK | Save
  • Prognostic value of (18)F-FDG PET/CT in diffuse large B-cell lymphoma treated with a risk-adapted immunochemotherapy regimen
    Journal Article

    Michaud, L.; Bantilan, K.; Mauguen, A.; Moskowitz, C. H.; Zelenetz, A. D.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Randomized phase III trial of ganitumab with interval-compressed chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma: A report from the Children's Oncology Group
    Journal Article

    DuBois, S. G.; Krailo, M. D.; Glade-Bender, J.; Buxton, A.; Laack, N.; Randall, R. L.; Chen, H. X.; Seibel, N. L.; Boron, M.; Terezakis, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Comparative efficacy of teclistamab versus physician's choice of therapy in the long-term follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS clinical trials in patients with triple-class exposed relapsed or refractory multiple myeloma
    Journal Article

    Mateos, M. V.; Chari, A.; Usmani, S. Z.; Goldschmidt, H.; Weisel, K.; Qi, K.; Londhe, A.; Nair, S.; Lin, X.; Pei, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplantation cyclophosphamide: Follow-up from a national marrow donor program-sponsored prospective clinical trial
    Journal Article

    Shaw, B. E.; Jimenez-Jimenez, A. M.; Burns, L. J.; Logan, B. R.; Khimani, F.; Shaffer, B. C.; Shah, N. N.; Mussetter, A.; Tang, X. Y.; McCarty, J. M.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Stem cell mobilization yields with daratumumab- and lenalidomide-containing quadruplet induction therapy in newly diagnosed multiple myeloma: Findings from the MASTER and GRIFFIN trials
    Journal Article

    Chhabra, S.; Callander, N.; Watts, N. L.; Costa, L. J.; Thapa, B.; Kaufman, J. L.; Laubach, J.; Sborov, D. W.; Reeves, B.; Rodriguez, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: Phase 1 UNIVERSAL trial interim results
    Journal Article

    Mailankody, S.; Matous, J. V.; Chhabra, S.; Liedtke, M.; Sidana, S.; Oluwole, O. O.; Malik, S.; Nath, R.; Anwer, F.; Cruz, J. C.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Prediction of nonrelapse mortality in patients with acute myeloid leukemia and acute lymphoblastic leukemia receiving allogeneic stem cell transplantation with posttransplantation cyclophosphamide-based graft versus host disease prophylaxis
    Journal Article

    Hermans, S. J. F.; Versluis, J.; Labopin, M.; Giebel, S.; van Norden, Y.; Moiseev, I.; Blaise, D.; Díez Martín, J. L.; Meijer, E.; Rovira, M.; more...
    HemaSphere (2023)

    Fulltext@MSK | Save